Regions Financial Corp’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.19M | Sell |
6,060
-468
| -7% | -$263K | 0.02% | 279 |
|
|
2026
Q1 | $3.67M | Sell |
6,528
-291
| -4% | -$187K | 0.02% | 267 |
|
|
2025
Q4 | $4.61M | Buy |
6,819
+5
| +0.1% | +$3.4K | 0.03% | 242 |
|
|
2025
Q3 | $4.35M | Sell |
6,814
-955
| -12% | -$580K | 0.03% | 261 |
|
|
2025
Q2 | $4.17M | Sell |
7,769
-71
| -0.9% | -$34K | 0.03% | 255 |
|
|
2025
Q1 | $3.29M | Sell |
7,840
-901
| -10% | -$391K | 0.02% | 281 |
|
|
2024
Q4 | $3.61M | Sell |
8,741
-2,118
| -20% | -$929K | 0.03% | 267 |
|
|
2024
Q3 | $5.49M | Sell |
10,859
-299
| -3% | -$145K | 0.04% | 223 |
|
|
2024
Q2 | $5.44M | Buy |
11,158
+119
| +1% | +$59.7K | 0.04% | 216 |
|
|
2024
Q1 | $5.96M | Buy |
11,039
+2,235
| +25% | +$1.22M | 0.05% | 210 |
|
|
2023
Q4 | $4.89M | Buy |
8,804
+202
| +2% | +$94.8K | 0.04% | 225 |
|
|
2023
Q3 | $3.76M | Sell |
8,602
-7
| -0.1% | -$3.49K | 0.03% | 248 |
|
|
2023
Q2 | $4.32M | Buy |
8,609
+249
| +3% | +$119K | 0.04% | 235 |
|
|
2023
Q1 | $4.18M | Sell |
8,360
-70
| -0.8% | -$33.5K | 0.04% | 233 |
|
|
2022
Q4 | $3.44M | Buy |
8,430
+4
| +0% | +$1.55K | 0.03% | 253 |
|
|
2022
Q3 | $2.75M | Sell |
8,426
-23
| -0.3% | -$8.45K | 0.03% | 275 |
|
|
2022
Q2 | $2.96M | Sell |
8,449
-51
| -0.6% | -$20.8K | 0.03% | 271 |
|
|
2022
Q1 | $4.65M | Buy |
8,500
+3
| +0% | +$1.58K | 0.04% | 236 |
|
|
2021
Q4 | $5.59M | Buy |
8,497
+2
| +0% | +$1.26K | 0.04% | 227 |
|
|
2021
Q3 | $5.28M | Sell |
8,495
-22
| -0.3% | -$14.8K | 0.05% | 216 |
|
|
2021
Q2 | $5.38M | Sell |
8,517
-434
| -5% | -$240K | 0.05% | 213 |
|
|
2021
Q1 | $4.38M | Sell |
8,951
-652
| -7% | -$327K | 0.04% | 230 |
|
|
2020
Q4 | $4.8M | Buy |
9,603
+75
| +0.8% | +$33.6K | 0.05% | 210 |
|
|
2020
Q3 | $3.75M | Buy |
9,528
+77
| +0.8% | +$28.5K | 0.04% | 218 |
|
|
2020
Q2 | $3.12M | Buy |
9,451
+6,074
| +180% | +$1.76M | 0.04% | 241 |
|
|
2020
Q1 | $818K | Buy |
+3,377
| New | +$881K | 0.01% | 411 |
|
|
2019
Q2 | – | Sell |
-190
| Closed | -$42K | – | 1219 |
|
|
2019
Q1 | $42K | Buy |
190
+14
| +8% | +$2.89K | ﹤0.01% | 1184 |
|
|
2018
Q4 | $33K | Sell |
176
-47
| -21% | -$9.64K | ﹤0.01% | 1242 |
|
|
2018
Q3 | $55K | Sell |
223
-161
| -42% | -$39.1K | ﹤0.01% | 1187 |
|
|
2018
Q2 | $84K | Sell |
384
-2,625
| -87% | -$541K | ﹤0.01% | 1072 |
|
|
2018
Q1 | $576K | Sell |
3,009
-1,135
| -27% | -$209K | 0.01% | 523 |
|
|
2017
Q4 | $648K | Sell |
4,144
-37
| -0.9% | -$5.82K | 0.01% | 511 |
|
|
2017
Q3 | $650K | Sell |
4,181
-47
| -1% | -$7.43K | 0.01% | 555 |
|
|
2017
Q2 | $683K | Sell |
4,228
-518
| -11% | -$84.1K | 0.01% | 549 |
|
|
2017
Q1 | $734K | Sell |
4,746
-340
| -7% | -$46.9K | 0.01% | 575 |
|
|
2016
Q4 | $597K | Sell |
5,086
-223
| -4% | -$25.4K | 0.01% | 617 |
|
|
2016
Q3 | $598K | Sell |
5,309
-372
| -7% | -$39.2K | 0.01% | 611 |
|
|
2016
Q2 | $527K | Sell |
5,681
-755
| -12% | -$64.8K | 0.01% | 631 |
|
|
2016
Q1 | $504K | Sell |
6,436
-61
| -0.9% | -$4.39K | 0.01% | 633 |
|
|
2015
Q4 | $473K | Buy |
6,497
+966
| +17% | +$68.9K | 0.01% | 643 |
|
|
2015
Q3 | $410K | Buy |
5,531
+2,135
| +63% | +$153K | 0.01% | 667 |
|
|
2015
Q2 | $218K | Sell |
3,396
-10,190
| -75% | -$705K | ﹤0.01% | 864 |
|
|
2015
Q1 | $1.05M | Sell |
13,586
-2,604
| -16% | -$203K | 0.01% | 503 |
|
|
2014
Q4 | $1.2M | Buy |
16,190
+50
| +0.3% | +$3.51K | 0.02% | 470 |
|
|
2014
Q3 | $951K | Sell |
16,140
-442
| -3% | -$27.9K | 0.01% | 605 |
|
|
2014
Q2 | $1.11M | Sell |
16,582
-1,034
| -6% | -$65.7K | 0.01% | 562 |
|
|
2014
Q1 | $1.07M | Sell |
17,616
-6,862
| -28% | -$409K | 0.01% | 562 |
|
|
2013
Q4 | $1.3M | Sell |
24,478
-13,824
| -36% | -$728K | 0.02% | 480 |
|
|
2013
Q3 | $1.91M | Buy |
38,302
+10,944
| +40% | +$526K | 0.03% | 330 |
|
|
2013
Q2 | $1.23M | Buy |
+27,358
| New | +$1.2M | 0.02% | 431 |
|
Other funds holding IDXX
Regions Financial Corp's IDXX Position: Q2 2026 in Review
Regions Financial Corp reduced its Idexx Laboratories (IDXX) stake by 7.2% in Q2 2026, selling an estimated $263K and leaving 6,060 shares worth $3.19M. The position accounts for 0.02% of the portfolio, ranked #279.
Regions Financial Corp first reported a position in IDXX in Q2 2013 and has held it in 50 quarters since. The position peaked at $5.96M in Q1 2024. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Regions Financial Corp held 6,060 shares of Idexx Laboratories worth $3.19M as of Q2 2026.
- Regions Financial Corp sold 468 Idexx Laboratories shares in Q2 2026, an estimated $263K.
- Idexx Laboratories made up 0.02% of Regions Financial Corp's portfolio in Q2 2026, its #279 holding.
- Regions Financial Corp first reported a position in Idexx Laboratories in Q2 2013 and has held it in 50 quarters since.
- Regions Financial Corp's Idexx Laboratories position peaked at $5.96M in Q1 2024.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Regions Financial Corp's 13F filing for Q2 2026, filed 10 Aug 2026.